Development of radiation pneumopathy and generalised radiological changes after radiotherapy are independent negative prognostic factors for survival in non-small cell lung cancer patients

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 382-388

  Farr, Katherina P ^a   Khalil, Azza A ^a   Knap, Marianne M ^a   Møller, Ditte S ^a   Grau, Cai ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Interstitial lung changes; Non small cell lung cancer; Radiation pneumonitis; Radiation induced pneumopathy; Radiotherapy

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; IRRADIATION; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION INJURY; RADIATION PNEUMOPATHY; SURVIVAL RATE;

INTERSTITIAL LUNG CHANGES; NON-SMALL CELL LUNG CANCER; RADIATION PNEUMONITIS; RADIATION-INDUCED PNEUMOPATHY; RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881474738     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.04.024     Document Type: Article

References (34)

1. L.B. Marks, S.M. Bentzen, and J.O. Deasy Radiation dose-volume effects in the lung Int J Radiat Oncol Biol Phys 76 2010 S70 S76
2. A. Inoue, H. Kunitoh, I. Sekine, M. Sumi, K. Tokuuye, and N. Saijo Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis Int J Radiat Oncol Biol Phys 49 2001 649 655
3. T.J. Robnett, M. Machtay, E.F. Vines, M.G. McKenna, K.M. Algazy, and W.G. McKenna Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer Int J Radiat Oncol Biol Phys 48 2000 89 94
4. J.Y. Wang, K.Y. Chen, and J.T. Wang Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis Int J Radiat Oncol Biol Phys 54 2002 735 741
5. Common Terminology Criteria for Adverse Events V 3.0 (CTCAE) (2006) http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3. pdf.
6. LENT SOMA tables Radiother Oncol 35 1995 17 60
7. P. Rubin, L.S. Constine, L.F. Fajardo, T.L. Phillips, and T.H. Wasserman RTOG late effects working group overview. Late effects of normal tissues (LENT) scoring system Int J Radiat Oncol Biol Phys 31 1995 1041 1042
8. M.M. Knap, L. Hoffmann, M. Nordsmark, and A. Vestergaard Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients Acta Oncol 49 2010 1077 1084
9. A. Fogliata, G. Nicolini, E. Vanetti, A. Clivio, and L. Cozzi Dosimetric validation of the anisotropic analytical algorithm for photon dose calculation: fundamental characterization in water Phys Med Biol 51 2006 1421 1438
10. M. Baumann, T. Herrmann, and R. Koch Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 2011 76 85
11. V. Mehta Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention Int J Radiat Oncol Biol Phys 63 2005 5 24
12. M.R. McCurdy, M.W. Wazni, J. Martinez, M.F. McAleer, and T. Guerrero Exhaled nitric oxide predicts radiation pneumonitis in esophageal and lung cancer patients receiving thoracic radiation Radiother Oncol 101 2011 443 448
13. G. Rodrigues, M. Lock, D. D'Souza, E. Yu, and J. Van Dyk Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer - a systematic review Radiother Oncol 71 2004 127 138
14. L. Claude, D. Perol, and C. Ginestet A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis Radiother Oncol 71 2004 175 181
15. I.R. Vogelius, and S.M. Bentzen A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis Acta Oncol 51 2012 975 983
16. Y.T. Oh, O.K. Noh, and H. Jang The features of radiation induced lung fibrosis related with dosimetric parameters Radiother Oncol 102 2012 343 346
17. S. Wang, Z. Liao, and X. Wei Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT) Int J Radiat Oncol Biol Phys 66 2006 1399 1407
18. M.R. McCurdy, R. Castillo, and J. Martinez 18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients Radiother Oncol 104 2012 52 57
19. N. Sanuki, A. Ono, and E. Komatsu Association of computed tomography-detected pulmonary interstitial changes with severe radiation pneumonitis for patients treated with thoracic radiotherapy J Radiat Res (Tokyo) 53 2012 110 116
20. C.M. Roberts, E. Foulcher, and J.J. Zaunders Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction Ann Intern Med 118 1993 696 700
21. G.W. Morgan, and S.N. Breit Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury Int J Radiat Oncol Biol Phys 31 1995 361 369
22. C. Martin, S. Romero, J. Sanchez-Paya, B. Massuti, J.M. Arriero, and L. Hernandez Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation Eur Respir J 13 1999 727 732
23. N. Barthelemy-Brichant, L. Bosquee, and D. Cataldo Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy Int J Radiat Oncol Biol Phys 58 2004 758 767
24. D. Arpin, D. Perol, and J.Y. Blay Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis J Clin Oncol 23 2005 8748 8756
25. F. Cappuccini, T. Eldh, and D. Bruder New insights into the molecular pathology of radiation-induced pneumopathy Radiother Oncol 101 2011 86 92
26. R.P. Hill, A. Zaidi, J. Mahmood, and S. Jelveh Investigations into the role of inflammation in normal tissue response to irradiation Radiother Oncol 101 2011 73 79
27. A. Takeda, T. Ohashi, and E. Kunieda Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors Int J Radiat Oncol Biol Phys 77 2010 685 690
28. K.M. Prise, and J.M. O'Sullivan Radiation-induced bystander signalling in cancer therapy Nat Rev Cancer 9 2009 351 360
29. M. Mancuso, E. Pasquali, and S. Leonardi Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum Proc Natl Acad Sci U S A 105 2008 12445 12450
30. K.T. Butterworth, C.K. McGarry, C. Trainor, J.M. O'Sullivan, A.R. Hounsell, and K.M. Prise Out-of-field cell survival following exposure to intensity-modulated radiation fields Int J Radiat Oncol Biol Phys 79 2011 1516 1522
31. K. Yamamoto, T. Kato, and J. Shindo A case of irinotecan or panitumumab-induced interstitial pneumonia successfully treated by steroid pulse therapy Gan Kagaku Ryoho 39 2012 305 309
32. M.P. Coleman, D. Forman, and H. Bryant Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Lancet 377 2011 127 138
33. M. Soliman, A. Yaromina, and S. Appold GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trial Radiother Oncol 106 2013 299 304
34. D.L. Ball, R.J. Fisher, and B.H. Burmeister The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05) Radiother Oncol 106 2013 305 311